"IBB" - iShares Biotechnology ETF twb tau zoo lawm txog 30% nyob rau tsib lub hlis dhau los tab sis Jefferies 'Michael Yee ntseeg tias nws tseem muaj chaw ntxiv rau qhov upside.
Yee's bull case rau biotech Tshuag
Yee pom ntau yam catalysts uas tuaj yeem thawb cov khoom lag luam no ntxiv mus rau lub hlis tom ntej.
Puas yog koj tab tom nrhiav kom tau cov xov xwm ceev, kub-cov lus qhia thiab kev tsom xam kev ua lag luam? Sau npe rau Invezz cov ntawv xov xwm, hnub no.
Pib nrog, biotech muaj lub zog peb lub hlis twg thiab qhov tseem ceeb tshaj, cov npe tseem ceeb hauv qhov chaw no tau tsa lawv cov kev taw qhia thiab. Qhov ntawd qhia tau tias muaj zog ntxiv. Yees kuj bullish vim:
Kev pom pom ntawm cov tshuaj mob qog noj ntshav thiab cov tshuaj ntshav qab zib tshiab thiab cov tshuaj rog rog tshiab tau zoo nkauj [paub meej] nyob rau kaum ob lub hlis tom ntej. Yog li, peb xav tias nws yog ib qho chaw zoo, tab sis peb tseem xav tias muaj ntau ntxiv mus.
Nyob rau hauv tas li ntawd, inflation zoo li yuav nqis los li Invezz qhia ntawm no. Hauv kev teb, yog tias Fed xaiv "pas", nws yuav tsim kom muaj ib puag ncig zoo rau kev lag luam macroeconomic. biotech khoom zoo li.
Biotech stocks tseem tsis kim
Piv rau qhov pib ntawm 2022, IBB tseem qis dua 10%.
Thiab qhov ntawd ua rau lwm qhov laj thawj vim li cas Yee pom zoo kev nqis peev hauv qhov kev pauv pauv pauv nyiaj no. Ntawm CNBC's “Fais Pluas Hmo”, nws hais tias:
Cov khoom lag luam no tau pheej yig heev. Txawm tias lawv nce 30% mus rau 40% tawm hauv qab, lawv tseem tsis kim. Yog li, peb tseem xav tias muaj chaw mus.
Hais txog cov npe ntawm tus kheej, nws tshwj xeeb tshaj yog bullish rau qhov nyiam ntawm Gilead Sciences Inc (NASDAQ: YOG) uas tseem ua lag luam zoo hauv qab qhov nruab nrab ntawm nws cov nqi-rau-cov nyiaj tau los piv rau tsib xyoos dhau los.
Luam cov kws ua lag luam yooj yim nrog eToro. Ua lag luam hauv Tshuag xws li Tesla & Apple. Instantly pauv ETFs zoo li FTSE 100 & S&P 500. Sau npe hauv feeb.
10/10
68% ntawm cov khw muag khoom CFD tso nyiaj poob